Ticks and tick-borne diseases represent a significant public health concern worldwide, posing threats to both human and animal populations. Ticks, arachnid parasites that feed on the blood of mammals, birds, and reptiles, serve as vectors for a variety of pathogens, including bacteria, viruses, and protozoa. Tick-borne diseases such as Lyme disease, Rocky Mountain spotted fever, and babesiosis can cause serious illness in humans, with symptoms ranging from mild fever and fatigue to severe neurological complications and even death. Prevention and control of tick-borne diseases require comprehensive strategies, including public education on tick bite prevention, habitat modification to reduce tick populations, and timely diagnosis and treatment of infections. Additionally, research efforts aimed at understanding tick biology, ecology, and pathogen transmission dynamics are essential for the development of effective prevention measures and therapeutics to mitigate the impact of tick-borne diseases on human and animal health.
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : When acute EBV mimics HIV: A case of false positive p24 antigen and low-level HIV antibody reactivity
Smriti Chaudhary, Imperial College Healthcare NHS Trust, United Kingdom
Title : OnePeru: Peruvian bioinformatics platform to contribute to the fight against antimicrobial resistance
Pool Marcos Carbajal, University of San Martin de Porres, Peru
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain